Previous Article | Next Article 
Journal of Clinical Microbiology, May 1998, p. 1441-1442, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Isolation of Influenza C Virus during an
Outbreak of Influenza A and B Viruses
Evgenia
Greenbaum,1
Avraham
Morag,2 and
Zichria
Zakay-Rones1,*
Virology Department1
and
Clinical Virology Unit,2 Hebrew
University-Hadassah Medical School, Jerusalem, Israel
Received 3 December 1997/Returned for modification 5 January
1998/Accepted 26 January 1998
 |
ABSTRACT |
During the winter of 1996 to 1997 two cases of influenza C were
confirmed, one by isolation and the second by serology (fourfold increase in hemagglutination inhibition antibodies). The cases of
influenza C occurred during an outbreak of influenza A
(H3N2) and B viruses. The positive isolation
was from one of three throat washings sent to the laboratory, and the
other case was from a group of 51 students participating in a study of
influenza virus vaccination. It seems, therefore, that influenza C
virus should also be considered when examining patients with
respiratory infections during the influenza season.
 |
TEXT |
Influenza C virus was first isolated
in the forties (1947), with sporadic cases reported (10).
Influenza C viruses occur primarily in a pattern of sporadic cases or
in limited outbreaks of mild illness involving children or young adults
(4, 8).
In a seroepidemiological study carried out in France in 1992, 61 to
70% of the population was found to have been previously exposed to the
virus, the highest rates for positive samples being found in the 16- to
30-year-old group. The results indicated intense circulation of
influenza C virus in the population (7).
During the influenza season attention is paid to influenza A and B
viruses in isolation efforts, as well as in serology studies. During
the influenza virus outbreak in the winter of 1996 to 1997, cases of
influenza C were found by isolation or by serology, as described in
this communication.
Case reports. (i) Patient 1.
A 27-year-old female came to the
clinic on 26 January 1997 with a high fever (39.5°C) that started on
that day. She complained of diffuse pains, mainly lower abdominal,
nausea with vomiting, runny nose, sore throat, coughing, weakness and
fever blisters on her lips. A 5-ml volume of throat washing in saline
was sent to the laboratory, together with two other samples from
patients suffering from similar symptoms.
(ii) Patient 2.
A 25-year-old female medical student was among
a group of 51 students participating in a study of intranasal influenza
virus vaccine efficacy for the 1996-to-1997 period (6).
After vaccination in the middle of November, the group was under
surveillance for respiratory infections until the end of March. Blood
samples for hemagglutination inhibition (HI) antibody tests were taken
from those complaining of respiratory symptoms. Nine vaccinees
complained of symptoms ranging from mild, without fever, to more
severe, with fever.
Isolation of virus.
A 0.1-ml volume of throat washing was
inoculated into the amniotic sacs, and a 0.2-ml volume was inoculated
into the allantoic cavities, of 10-day-old embryonated eggs, which were
incubated for 72 h at 34°C. The first two passages (three and
five eggs) were negative, while on the third passage, three of five
showed respective hemagglutination titers of 1:16, 1:4, and 1:32. The blind passages were performed with samples from a pool of infected amniotic allantoic fluids. Hemagglutination was stable at 4°C but
eluted rapidly, within 20 min, at room temperature. MDCK cells were
simultaneously infected, with no isolation success following three
consecutive passages. However, virus from the third passage from eggs
replicated in MDCK cells, as evidenced by the hemagglutination of
supernatants and hemadsorption at 4°C. The titer was
103.5 50% tissue culture infective doses
(TCID50) in the presence of trypsin (2 µg/ml) and only
101.5 TCID50 without trypsin. Cytopathic
effect, described for some influenza C virus strains (2),
was not observed. The virus isolated from eggs was inhibited by
antisera to C/Taylor/1233/47 (1:320) and C/Johannesburg 1/66 (1:320)
(kindly provided by N. Versanon of the Central Viral Laboratory, Tel
Hashomer, Israel).
The identity of isolate C/Jerusalem/2/97 was further confirmed by
A. R. Douglas and A. Hay (World Health Organization Collaborative Center for Reference and Research on Influenza, National Institute for
Medical Research, Ridgeway, Mill Hill, London, United Kingdom), and the
isolate was found to be similar to C/Johannesburg/1/66.
The isolate was insensitive to inhibitors of normal horse serum but was
inhibited by normal rat serum (1:320 to 1:640 dilution).
The inhibiting
substance could not be removed from the rat serum
by heating for 30 min
at 58°C.
There can be no question of contamination from other sources, since
this is our first encounter with the influenza C virus.
Serological testing.
Sera from all nine volunteers complaining
of respiratory infections were evaluated for rise in HI antibodies
against the three recently isolated influenza A virus strains
(A/Texas/36/91 [H1N1], A/Nanchang/933/95
[H3N2], and B/Harbin/7/94), and against the influenza C virus isolate. HI testing was performed by the standard microtiter technique (11) in twofold dilutions, starting at 1:5. The serum was pretreated with receptor destroying enzyme (Sigma
Chemical Co., St. Louis, Mo.) for 18 h at 37°C and then was
inactivated (56°C for 30 min) and tested against four
hemagglutination units of each of the influenza virus strains. Of the
nine cases tested, three had fourfold rises in HI antibodies, one to
B/Harbin, one to A/Nanchang, and one to C/Jerusalem/2/97 (1:5 to 1:20). For the last case, the student had low fever for 3 to 4 days and a
runny nose at the end of January. She was immune to Texas/91 and
A/Nanchang/95. She had no rise in HI antibodies to B/Harbin, to which
she was not immune.
Discussion.
During the winter, infection with influenza C
virus coincides with influenza A (H3N2 and
H1N1) and B virus activity. The influenza C
cases may exhibit symptoms with a severity similar to that caused by
influenza A or B virus, and it is therefore important to better understand the epidemiology of this virus and its exact role in acute
viral respiratory infections.
In France a high prevalence of antibodies, as well as significant
titers, indicates intense circulation of influenza C virus,
especially
among young adults (
7). In Japan 18 influenza C
virus
strains infecting humans were found with monoclonal antibodies
to
hemagglobulin esterase glycoprotein and were included in three
distinct
groups closely related to C/Yamagata/26/81, C/Aichi/1/81,
and
C/Mississippi/80 (
5).
Influenza C virus was thought to infect humans only but was isolated
from swine in China (
1). The close relationship of
strains
from humans to isolates from pigs that was found and the
possibility of
interspecies transmission of the influenza C virus
between humans and
pigs (
5) further indicate the potential
involvement of the
virus in respiratory infections. The finding
of persistent infection in
chicken lungs in vitro (
3), as well
as the fact that
frequent genetic reassortment between influenza
C virus strains occurs
in nature (
9), calls for broadening
this study.
It is possible that because of more efficient control of influenza A
and B viruses by vaccination and/or antiviral drugs,
influenza C virus
could have a better chance of persisting, leading
to more cases being
identified.
 |
ACKNOWLEDGMENTS |
We are indebted to Avi Izhak from Rishon LeZion for sending us
samples.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Virology, Hebrew University-Hadassah Medical School, P.O.B. 12272, Jerusalem 91120, Israel. Phone: 972-2-6758554. Fax: 972-2-6784010. E-mail: rones{at}cc.huji.ac.il.
 |
REFERENCES |
| 1.
|
Guo, Y.,
J. F. Wang,
M. Wang, and J. Zhu.
1983.
Isolation of influenza C from pigs and experimental infection of pigs with influenza C virus.
J. Gen. Virol.
64:177-182[Abstract/Free Full Text].
|
| 2.
|
Hechtfischer, A.,
M. Marschall,
A. Helten,
C. Boswald, and H. Meier-Ewert.
1997.
A highly cytopathogenic influenza C virus variant induces apoptosis in cell culture.
J. Gen. Virol.
78:1327-1330[Abstract].
|
| 3.
|
Helten, A.,
M. Marschall, and A. J. Reininger.
1996.
Experimental infection with a persistent influenza C virus variant leads to prolonged genome detection in the chicken lung.
Acta Virol.
40:223-226[Medline].
|
| 4.
|
Joosting, A. C. C.,
B. Head,
M. L. Bynoe, and D. A. L. Tyrrell.
1968.
Production of common colds in human volunteers by influenza C virus.
Br. Med. J.
4:153-154.
|
| 5.
|
Kimura, H.,
C. Abiko,
G. Peng,
K. Sugawara,
S. Hongo,
F. Kitame,
K. Mizuta,
Y. Numazaki,
H. Suzuki, and K. Nakamura.
1997.
Interspecies transmission of influenza C virus between humans and pigs.
Virus Res.
48:71-79[Medline].
|
| 6.
|
Levy, R.,
G. Greenbaum,
M. Schlesinger,
D. Engelhard,
A. Morag, and Z. Zakay-Rones.
1997.
Intranasal immunization with inactive influenza vaccine an alternative to injection for humoral antibody response. Presented at the 2nd National Symposium on Basic Aspects of Vaccines, Bethesda, Md
.
|
| 7.
|
Manuguerra, J.-C.,
C. Hannoun, and M. Aymard.
1992.
Influenza C virus infection in France.
J. Infect.
24:91-99[Medline].
|
| 8.
|
Minuse, E.,
J. J. Quilligan, and T. Francis.
1954.
Type C influenza virus. 1. Studies of the virus and its distribution.
J. Lab. Clin. Med.
43:31-42[Medline].
|
| 9.
|
Peng, G.,
S. Hongo,
H. Kimura,
Y. Muraki,
K. Sugawara,
F. Kitame,
Y. Numazaki,
H. Suzuki, and K. Nakamura.
1996.
Frequent occurrence of genetic reassortment between influenza C virus strains in nature.
J. Gen. Virol.
77:1489-1492[Abstract/Free Full Text].
|
| 10.
|
Taylor, R. M.
1951.
A further note on 1233 (influenza C) virus.
Arch. Gesamte Virusforsch.
4:485-500[Medline].
|
| 11.
|
U.S. Department of Health and Welfare.
1975.
Advanced laboratory techniques for influenza diagnosis. Immunology Series 6. Procedural guide. U.S. Department of Health and Welfare publication no. 25-61. U.S.
Department of Health and Welfare, Washington, D.C.
|
Journal of Clinical Microbiology, May 1998, p. 1441-1442, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.